Grosshans E, Woehl M
Ann Dermatol Venereol. 1982;109(2):151-62.
Putting forward disturbances of cutaneous vasomotricity, sweating and sebaceous excretion is of slight diagnostical value in atopy, but contributes to a better knowledge of its physiopathology. Abnormal vascular reactions are probably correlated with a functional disturbance of beta-adrenergic receptors of the blood vessels; clinical symptoms of apparently paradoxical vasoconstriction occur in most cases of atopic dermatitis, i. e. white dermographism in 80 p. 100, delayed cholinergic blanch in 70 p. 100 or absence of erythema to rubefacients in 55 to 70 p. 100. The troubles of eccrine sweating are more complex: in the eczematous lesions there is a spontaneous and experimentally provoked increase of sweating; in atopic patients the level of acetylcholine induced sweating is lowered and the mean excretion rate is increased; these parameters are not modified by beta-blockers which enhance cholinergic sweating in normals. On the contrary, in atopics beta 2-agonists increase eccrine sweating in summer, but become inefficient in autumn and winter, just as if there was a less severe beta-blockade during warm season. In atopics, sweat is mainly of the cholinergic type and contains more chlorides and less acid mucopolysaccharides; therefore its tensio-activity is increased and its thermolytic evaporative rate correlatively decreased; eccrine sweat glands of atopics are less able to adapt to wintry adrenergic stress, because catecholamines stimulate in preference the dark muciparous cells of the glomerular coil. Eccrine sweat of atopics contains also high amounts of IgE and that is probably the reason of its whealing effect by intradermal injection. The cutaneous dryness of atopic patients seems unrelated to these sudoral troubles, but rather to a excessive transepidermal water loss due to the extensive eczematous microscopical spongiosis of the epidermis and the loss of the barrier function of its horny layer. Decrease of the sebaceous secretion contributes also to the xerosis and following disturbances have been registered: decrease of the total excretion rate, decrease of the lipids of sebo-glandular origin such as waxes, squalen and triglycerides, higher amount of cholesterol, decrease of surfaces and density of sebaceous glands and lower labelling of cells in S phase. Troubles of apocrine sweating have not yet been reported. Abnormal vasomotor, sudoral and sebaceous functions in atopic patients can be satisfactorily interpreted if one accepts the theory of a constitutional blockade of beta 2- and H2-receptors.
提出皮肤血管舒缩功能、出汗及皮脂分泌紊乱在特应性疾病中的诊断价值不大,但有助于更好地了解其生理病理学。异常的血管反应可能与血管β - 肾上腺素能受体的功能紊乱有关;明显矛盾性血管收缩的临床症状在大多数特应性皮炎病例中出现,即80%的患者有白色皮肤划痕症,70%的患者有延迟性胆碱能性皮肤苍白,55%至70%的患者对摩擦剂无红斑反应。小汗腺出汗障碍更为复杂:在湿疹性皮损处有自发性及实验性诱发的出汗增加;特应性患者中乙酰胆碱诱导的出汗水平降低而平均排泄率增加;β受体阻滞剂可增强正常人的胆碱能性出汗,但对这些参数无影响。相反,在特应性患者中,β2激动剂在夏季可增加小汗腺出汗,但在秋冬季节则无效,就好像在温暖季节存在较轻的β受体阻滞一样。在特应性患者中,汗液主要为胆碱能型,含有更多的氯化物和更少的酸性粘多糖;因此其表面张力增加,热分解蒸发率相应降低;特应性患者的小汗腺对冬季肾上腺素能应激的适应能力较差,因为儿茶酚胺优先刺激肾小球卷曲部的深色粘液分泌细胞。特应性患者的小汗腺汗液中也含有大量的IgE,这可能是其皮内注射后出现风团效应的原因。特应性患者的皮肤干燥似乎与这些出汗障碍无关,而是与表皮广泛的湿疹性显微镜下海绵形成及其角质层屏障功能丧失导致的经表皮水分过度流失有关。皮脂分泌减少也导致皮肤干燥,且已记录到以下变化:总排泄率降低,皮脂腺源性脂质如蜡、角鲨烯和甘油三酯减少,胆固醇含量增加,皮脂腺表面积和密度降低,S期细胞标记减少。顶泌汗腺出汗障碍尚未见报道。如果接受β2和H2受体先天性阻滞的理论,特应性患者的血管舒缩、出汗及皮脂功能异常就能得到满意的解释。